EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2-Reference-Cited by-同舟云学术

EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

Published:2020-06-05 Issue:7 Volume:79 Page:851-858
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Landewé Robert BM^ORCID,Machado Pedro M^ORCID,Kroon Féline^ORCID,Bijlsma Hans WJ,Burmester Gerd R,Carmona Loreto,Combe Bernard,Galli Massimo,Gossec Laure^ORCID,Iagnocco Annamaria,Isaacs John D^ORCID,Mariette Xavier,McInnes Iain,Mueller-Ladner Ulf,Openshaw Peter,Smolen Josef S,Stamm Tanja A^ORCID,Wiek Dieter,Schulze-Koops Hendrik^ORCID

Abstract

The provisional EULAR recommendations address several aspects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus, and the disease caused by SARS-CoV-2, COVID-19 and are meant for patients with rheumatic and musculoskeletal diseases (RMD) and their caregivers. A task force of 20 members was convened by EULAR that met several times by videoconferencing in April 2020. The task force finally agreed on five overarching principles and 13 recommendations covering four generic themes: (1) General measures and prevention of SARS-CoV-2 infection. (2) The management of RMD when local measures of social distancing are in effect. (3) The management of COVID-19 in the context of RMD. (4) The prevention of infections other than SARS-CoV-2. EULAR considers this set of recommendations as a ‘living document’ and a starting point, which will be updated as soon as promising new developments with potential impact on the care of patients with RMD become available.

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference26 articles.

1. 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations

2. Commission for pharmacotherapy and the Board of the German Society for rheumatology e.V. Aktuelle Handlungsempfehlungen Der Deutschen Gesellschaft für Rheumatologie e.V. für die Betreuung von Patienten MIT rheumatischen Erkrankungen während Der SARS-CoV-2/Covid 19-Pandemie. Available: https://dgrh.de/Start/Publikationen/Empfehlungen/Therapie-bei-besonderen-Situationen/Empfehlungen-w%C3%A4hrend-der-SARS-CoV-2-Covid-19-Pandemie.html [Accessed 24 Mar 2020].

3. Filière de santé maladies rares . Recommandations COVID-19 : Patients atteints de maladies auto-immunes ou auto-inflammatoires. Available: https://www.fai2r.org/actualites/covid-19 [Accessed 09 Apr 2020].

4. Société Française de Rhumatologie . Réponse donner aux patients qui posent des questions SUR Le Risque que constitue leur traitement face Au COVID-19. Available: https://sfr.larhumatologie.fr/actualites/reponse-donner-aux-patients-qui-posent-questions-risque-que-constitue-leur-traitement [Accessed 17 Mar 2020].

5. La Sociedad Española de Reumatología . El coronavirus COVID-19 Y Los pacientes Con Enfermedades reumáticas. Available: https://www.ser.es/el-coronavirus-covid-19-y-los-pacientes-con-enfermedades-reumaticas/ [Accessed 31 Mar 2020].

Cited by 220 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies;Joint Bone Spine;2024-03

2. The impact of COVID-19 on clinical research: the PIPPRA and MEDRA experience;HRB Open Research;2023-11-10

3. COVID-19 vaccination and infection status: a cross-sectional survey of patients with rheumatic diseases in China;Rheumatology International;2023-10-28

4. Communication to promote and support physical distancing for COVID-19 prevention and control;Cochrane Database of Systematic Reviews;2023-10-09

5. COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology;Lupus Science & Medicine;2023-10